Back
Quantum Computing 10K Form
Sell
47
QUBT
Quantum Computing
Last Price:
$15.15
Seasonality Move:
111.13%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-03-27 | 10K | QUBT/Quantum Computing Annual |
2019-11-13 | 10Q | QUBT/Quantum Computing Quarterly |
2019-08-02 | 10Q | QUBT/Quantum Computing Quarterly |
2019-06-07 | 10K | QUBT/Quantum Computing Annual |
2019-06-07 | 10Q | QUBT/Quantum Computing Quarterly |
2019-05-14 | 10Q | QUBT/Quantum Computing Quarterly |
Receive QUBT News And Ratings
See the #1 stock for the next 7 days that we like better than QUBT
QUBT Financial Statistics
Sales & Book Value
Annual Sales: | $358K |
---|---|
Cash Flow: | $0 |
Price / Cash Flow: | 0 |
Annual Sales: | $0.00 |
Price / Book: | 0 |
Profitability
Net Income (TTM): | $0 |
---|---|
Gross Margin: | $162K |
Return on Equity: | 0% |
Return on Assets: | 0% |
Quantum Computing Earnings Forecast
Key Quantum Computing Financial Ratios
-
The Gross Profit Margin over the past 5 years for QUBT is 45.25%.
-
The Selling, General & Administrative Expenses for QUBT have been equal to 4,892.18% of Gross Profit Margin.
-
The Research & Development expenses have been 2,483.52% of Revenue.
-
The Interest Expense is -5.93% of Operating Income.
-
The Net Earning history of QUBT is -7,548.04% of Total Revenues.
-
Per Share Earnings over the last 5 years have been positive in 3 years.
Quantum Computing Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | QUBT |
Website: | quantumcomputinginc.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
QUBT Technical Analysis vs Fundamental Analysis
Sell
47
Quantum Computing (QUBT)
is a Sell
Is Quantum Computing a Buy or a Sell?
-
Quantum Computing stock is rated a SellThe current Quantum Computing [QUBT] share price is $25.62. The Score for QUBT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.